147 related articles for article (PubMed ID: 32199594)
21. Impact of FOXL2 mutations on signaling in ovarian granulosa cell tumors.
Leung DTH; Fuller PJ; Chu S
Int J Biochem Cell Biol; 2016 Mar; 72():51-54. PubMed ID: 26791928
[TBL] [Abstract][Full Text] [Related]
22. Molecular pathogenesis in granulosa cell tumor is not only due to somatic FOXL2 mutation.
Wang WC; Lai YC
J Ovarian Res; 2014 Sep; 7():88. PubMed ID: 25297715
[TBL] [Abstract][Full Text] [Related]
23. Correlation of FOXL2 with Inhibin and Calretinin in the Diagnosis of Ovarian Sex Cord Stromal Tumors.
Rathore R; Arora D; Agarwal S; Sharma S
Turk Patoloji Derg; 2017; 33(2):121-128. PubMed ID: 28272677
[TBL] [Abstract][Full Text] [Related]
24. Absence of a FOXL2 mutation (402C→G) in the blood of adult-type granulosa cell tumor patients possessing the FOXL2 mutation.
Lee S; Kim TH; Won M; Ko JJ; Rho J; Lee K; Bae J
Int J Gynecol Cancer; 2010 Nov; 20(8):1341-3. PubMed ID: 21051974
[TBL] [Abstract][Full Text] [Related]
25. DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study.
Goulvent T; Ray-Coquard I; Borel S; Haddad V; Devouassoux-Shisheboran M; Vacher-Lavenu MC; Pujade-Laurraine E; Savina A; Maillet D; Gillet G; Treilleux I; Rimokh R
Histopathology; 2016 Jan; 68(2):279-85. PubMed ID: 26033501
[TBL] [Abstract][Full Text] [Related]
26. Mutant FOXL2
Weis-Banke SE; Lerdrup M; Kleine-Kohlbrecher D; Mohammad F; Sidoli S; Jensen ON; Yanase T; Nakamura T; Iwase A; Stylianou A; Abu-Rustum NR; Aghajanian C; Soslow R; Da Cruz Paula A; Koche RP; Weigelt B; Christensen J; Helin K; Cloos PAC
Cancer Res; 2020 Sep; 80(17):3466-3479. PubMed ID: 32641411
[TBL] [Abstract][Full Text] [Related]
27. FOXL2 in adult-type granulosa cell tumour of the ovary: oncogene or tumour suppressor gene?
Pilsworth JA; Todeschini AL; Neilson SJ; Cochrane DR; Lai D; Anttonen M; Heikinheimo M; Huntsman DG; Veitia RA
J Pathol; 2021 Nov; 255(3):225-231. PubMed ID: 34338304
[TBL] [Abstract][Full Text] [Related]
28. Composite Serous Borderline Tumor and Adult Granulosa Cell Tumor-like Area: Is it a True Neoplastic AGCT or Tumor-like Proliferation?
Yu J; Nie X
Int J Gynecol Pathol; 2017 May; 36(3):265-269. PubMed ID: 27648785
[TBL] [Abstract][Full Text] [Related]
29. Immunoexpression of inhibin alpha subunit, inhibin/activin betaA subunit and CD99 in ovarian tumors.
Choi YL; Kim HS; Ahn G
Arch Pathol Lab Med; 2000 Apr; 124(4):563-9. PubMed ID: 10747314
[TBL] [Abstract][Full Text] [Related]
30. Granulosa cell tumors of unilocular cystic type.
Mulvany NJ; Riley CB
Pathology; 1997 Nov; 29(4):348-53. PubMed ID: 9423213
[TBL] [Abstract][Full Text] [Related]
31. Aberrant granulosa cell-fate related to inactivated p53/Rb signaling contributes to granulosa cell tumors and to FOXL2 downregulation in the mouse ovary.
Cluzet V; Devillers MM; Petit F; Chauvin S; François CM; Giton F; Genestie C; di Clemente N; Cohen-Tannoudji J; Guigon CJ
Oncogene; 2020 Feb; 39(9):1875-1890. PubMed ID: 31745296
[TBL] [Abstract][Full Text] [Related]
32. The FOXL2 mutation (c.402C>G) in adult-type ovarian granulosa cell tumors of three Japanese patients: clinical report and review of the literature.
Takahashi A; Kimura F; Yamanaka A; Takebayashi A; Kita N; Takahashi K; Murakami T
Tohoku J Exp Med; 2013 Dec; 231(4):243-50. PubMed ID: 24257635
[TBL] [Abstract][Full Text] [Related]
33. [Application of molecular analysis in differential diagnosis of ovarian adult granulosa cell tumors].
Zheng XZ; Ma JH; Chen TB; Xu F; Zou ZY; Zhang LH; Jin YL; Zhan Y
Zhonghua Bing Li Xue Za Zhi; 2020 Aug; 49(8):794-799. PubMed ID: 32746545
[No Abstract] [Full Text] [Related]
34. The Pathognomonic FOXL2 C134W Mutation Alters DNA-Binding Specificity.
Carles A; Trigo-Gonzalez G; Cao Q; Cheng SG; Moksa M; Bilenky M; Huntsman DG; Morin GB; Hirst M
Cancer Res; 2020 Sep; 80(17):3480-3491. PubMed ID: 32641414
[TBL] [Abstract][Full Text] [Related]
35. Clinical and genetic analysis of recurrent adult-type granulosa cell tumor of the ovary: Persistent preservation of heterozygous c.402C>G FOXL2 mutation.
Yanagida S; Anglesio MS; Nazeran TM; Lum A; Inoue M; Iida Y; Takano H; Nikaido T; Okamoto A; Huntsman DG
PLoS One; 2017; 12(6):e0178989. PubMed ID: 28594898
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical staining of ovarian granulosa cell tumors with monoclonal antibody against inhibin.
McCluggage WG; Maxwell P; Sloan JM
Hum Pathol; 1997 Sep; 28(9):1034-8. PubMed ID: 9308727
[TBL] [Abstract][Full Text] [Related]
37. Mutational analysis of FOXL2 p.C134W and expression of bone morphogenetic protein 2 in Japanese patients with granulosa cell tumor of ovary.
Oseto K; Suzumori N; Nishikawa R; Nishikawa H; Arakawa A; Ozaki Y; Asai H; Kawai M; Mizuno K; Takahashi S; Shirai T; Yamada-Namikawa C; Nakanishi M; Kajiyama H; Kikkawa F; Sugiura-Ogasawara M
J Obstet Gynaecol Res; 2014 May; 40(5):1197-204. PubMed ID: 24689977
[TBL] [Abstract][Full Text] [Related]
38. FOXL2, GATA4, and SMAD3 co-operatively modulate gene expression, cell viability and apoptosis in ovarian granulosa cell tumor cells.
Anttonen M; Pihlajoki M; Andersson N; Georges A; L'hôte D; Vattulainen S; Färkkilä A; Unkila-Kallio L; Veitia RA; Heikinheimo M
PLoS One; 2014; 9(1):e85545. PubMed ID: 24416423
[TBL] [Abstract][Full Text] [Related]
39. A current perspective on the pathological assessment of FOXL2 in adult-type granulosa cell tumours of the ovary.
Kommoss S; Gilks CB; Penzel R; Herpel E; Mackenzie R; Huntsman D; Schirmacher P; Anglesio M; Schmidt D; Kommoss F
Histopathology; 2014 Feb; 64(3):380-8. PubMed ID: 24192202
[TBL] [Abstract][Full Text] [Related]
40. An alternative miRISC targets a cancer-associated coding sequence mutation in FOXL2.
Shin E; Jin H; Suh DS; Luo Y; Ha HJ; Kim TH; Hahn Y; Hyun S; Lee K; Bae J
EMBO J; 2020 Dec; 39(24):e104719. PubMed ID: 33215742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]